Ignite Creation Date:
2025-12-24 @ 11:44 PM
Ignite Modification Date:
2026-01-29 @ 8:20 PM
Study NCT ID:
NCT05867251
Status:
RECRUITING
Last Update Posted:
2025-11-19
First Post:
2023-04-13
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study of AVZO-021 in Patients With Advanced Solid Tumors
Sponsor:
Avenzo Therapeutics, Inc.
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Advanced Solid Tumor | View |
| None | HR+/HER2- Breast Cancer | View |
| None | HR+, HER2-, Advanced Breast Cancer | View |
| None | CCNE1 Amplification | View |
| None | Epithelial Ovarian Cancer | View |
| None | Primary Peritoneal Cancer | View |
| None | Fallopian Tube Cancer | View |
| None | Endometrial Cancer | View |
| None | TNBC - Triple-Negative Breast Cancer | View |
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | Advanced solid tumor | View |
| None | HR+/HER2- Breast Cancer | View |
| None | Breast Cancer | View |
| None | Advanced Breast Cancer | View |
| None | CCNE1 Amplification | View |
| None | Epithelial Ovarian Cancer | View |
| None | Primary Peritoneal Cancer | View |
| None | Fallopian Tube Cancer | View |
| None | Endometrial Cancer | View |
| None | Triple Negative Breast Cancer | View |